» Articles » PMID: 24040099

Overexpression of Arginine Transporter CAT-1 is Associated with Accumulation of L-arginine and Cell Growth in Human Colorectal Cancer Tissue

Overview
Journal PLoS One
Date 2013 Sep 17
PMID 24040099
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

We previously showed that L-arginine (Arg) accumulates in colorectal cancer tissues. The aim of this study was to investigate the mechanism by which Arg accumulates and determine its biological significance. The concentration of Arg and Citrulline (Cit) in sera and tumor tissues from colorectal cancer (CRC) patients was analyzed by high-performance liquid chromatography (HPLC). The expression of Arg transporters was analyzed by quantitative reverse transcription polymerase chain reaction (qRT-PCR) and immunohistochemical analysis of tissue microarray. We also transfected the colon cancer cell line HCT-116 with siRNA specific for the Arg transporter CAT-1 and measured the induction of apoptosis by flow cytometry and cell proliferation by MTT assay. Consistent with our previous results, serum Arg and Cit concentrations in colorectal cancer patients were significantly lower than those in normal volunteers, while Arg and Cit concentrations in colorectal cancer tissues were significantly higher than in matched adjacent normal colon tissues. Quantitative RT-PCR showed that the CAT-1 gene was highly overexpressed in 70.5% of colorectal cancer tissue samples relative to adjacent normal colon tissues in all 122 patients with colorectal cancer. Immunohistochemical analysis of tissue microarray confirmed that the expression of CAT-1 was higher in all 25 colorectal cancer tissues tested. CAT-1 siRNA significantly induced apoptosis of HCT-116 cells and subsequently inhibited cell growth by 20-50%. Our findings indicate that accumulation of L-Arg and Cit and cell growth in colorectal cancer tissues is associated with over-expression of the Arg transporter gene CAT-1. Our results may be useful for the development of molecular diagnostic tools and targeted therapy for colorectal cancer.

Citing Articles

Plant Metabolomics: The Future of Anticancer Drug Discovery.

Dabbousy R, Rima M, Roufayel R, Rahal M, Legros C, Sabatier J Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39458949 PMC: 11510165. DOI: 10.3390/ph17101307.


Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy.

Hushmandi K, Einollahi B, Saadat S, Lee E, Farani M, Okina E Mol Metab. 2024; 84:101952.

PMID: 38705513 PMC: 11112377. DOI: 10.1016/j.molmet.2024.101952.


Modulation of Cisplatin Sensitivity through TRPML1-Mediated Lysosomal Exocytosis in Ovarian Cancer Cells: A Comprehensive Metabolomic Approach.

Kim B, Kim G, Kim H, Song Y, Jung J Cells. 2024; 13(2).

PMID: 38247807 PMC: 10814698. DOI: 10.3390/cells13020115.


Identification of potential molecular targets for the treatment of cluster 1 human pheochromocytoma and paraganglioma via comprehensive proteomic characterization.

Vit O, Talacko P, Musil Z, Hartmann I, Pacak K, Petrak J Clin Proteomics. 2023; 20(1):39.

PMID: 37749499 PMC: 10518975. DOI: 10.1186/s12014-023-09428-7.


HIF: a master regulator of nutrient availability and metabolic cross-talk in the tumor microenvironment.

Missiaen R, Lesner N, Simon M EMBO J. 2023; 42(6):e112067.

PMID: 36808622 PMC: 10015374. DOI: 10.15252/embj.2022112067.


References
1.
Laplante M, Sabatini D . mTOR signaling in growth control and disease. Cell. 2012; 149(2):274-93. PMC: 3331679. DOI: 10.1016/j.cell.2012.03.017. View

2.
Rotondo R, Mastracci L, Piazza T, Barisione G, Fabbi M, Cassanello M . Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression. Int J Cancer. 2008; 123(5):1108-16. DOI: 10.1002/ijc.23437. View

3.
Mao H, Wei W, Xiong W, Lu Y, Chen B, Liu Z . Simultaneous determination of l-citrulline and l-arginine in plasma by high performance liquid chromatography. Clin Biochem. 2010; 43(13-14):1141-7. DOI: 10.1016/j.clinbiochem.2010.05.017. View

4.
Morris Jr S . Arginine: master and commander in innate immune responses. Sci Signal. 2010; 3(135):pe27. DOI: 10.1126/scisignal.3135pe27. View

5.
Huang C, Chiribau C, Majumder M, Chiang C, Wek R, Kelm Jr R . A bifunctional intronic element regulates the expression of the arginine/lysine transporter Cat-1 via mechanisms involving the purine-rich element binding protein A (Pur alpha). J Biol Chem. 2009; 284(47):32312-20. PMC: 2781645. DOI: 10.1074/jbc.M109.024471. View